SCHEMBL6071173

SCHEMBL6071173

CC(C)=CC(=O)Nc1ccc2[nH]c3c(c2c1)CCc1cn[nH]c1-3

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 19/20 0.58
KDM4E B2RXH2 3/20 0.58
MEN1 O00255 3/20 0.58
ALDH1A1 P00352 3/20 0.58
LMNA P02545 3/20 0.58
MAPT P10636 3/20 0.58
KMT2A Q03164 3/20 0.58
HSD17B10 Q99714 3/20 0.58
MAPK1 P28482 2/20 0.58
TSHR P16473 2/20 0.58
RAB9A P51151 2/20 0.58
NPC1 O15118 1/20 0.58
MPI P34949 1/20 0.58
RIPK1 Q13546 17/20 0.56
USP2 O75604 1/20 0.56
HSP90AA1 P07900 1/20 0.56
ALOX15 P16050 1/20 0.56
GFER P55789 1/20 0.56
AURKA O14965 1/20 0.52
HPGD P15428 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070746 0.89 MAPK10 (0.63) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL6070939 0.85 MAPK10 (0.61) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL6071065 0.84 MAPK10 (0.60) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL6070579 0.84 MAPK10 (0.62) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL6070716 0.83 MAPK10 (0.61) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL5583211 0.83 MAPK10 (0.58) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL6070589 0.82 MAPK10 (0.59) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL6070395 0.82 MAPK10 (0.59) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL6071625 0.82 MAPK10 (0.54) MAPK10KDM4EMEN1ALDH1A1LMNA
SCHEMBL6070799 0.82 MAPK10 (0.56) MAPK10KDM4EMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K1, MAP3K19, MAP3K20 MAPK10 387/4885KDM4E 1799/4885MEN1 2523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.